Rebecca Araujo

Urban Health Today

DocWire News spoke with Douglas Sborov, MD, Director of the Multiple Myeloma Program, Huntsman Cancer Institute at the University of Utah, about recent initiatives to expand eligibility to multiple myeloma (MM) clinical trials, and the challenges this may present.This is the final of a two-part discussion with Dr. Sborov. Watch <a href="https://www.docwirenews.com/condition-center/multiple-myeloma-knowledge-hub/multiple-myeloma-care-during-the-pandemic-with-dr-sborov/">part one</a>, where he discusses MM care during the pandemic.

Payton White, BS

How Sleep Quality Influences Risk of Alzheimer’s Disease

Alzheimer's & Dementia

Lou Portero

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Latest News

Dr. Sborov Discusses Expanding Access to MM Clinical Trials

Multiple Myeloma

DocWire News spoke with Douglas Sborov, MD, Director of the Multiple Myeloma Program, Huntsman Cancer Institute at the ...

Dr. Sborov on Expanding Access to MM Clinical Trials

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe